Immunotherapy-boosted chemo shows striking early results against high-risk nasopharyngeal cancer
A prospective phase II pilot study from non-endemic Sichuan reports 95.2 percent response rates and 80 percent event-free survival at...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A prospective phase II pilot study from non-endemic Sichuan reports 95.2 percent response rates and 80 percent event-free survival at...
The practical framework outlined by Zhang and Madlensky arrives at a moment when the infrastructure of precision oncology is being...
A new review in Cancer Cell International synthesizes contemporary classification, clonal biology, and precision therapy for mixed phenotype acute leukemia,...
A new review in Molecular Biology Reports surveys how fluorogenic RNA aptamers, engineered RNA strands that switch on fluorescence upon...
Mayo Clinic researchers developed an artificial intelligence model that uses routine electronic health record data to predict pancreatic cancer risk...
A 21-year national analysis of CDC mortality data finds that deaths associated with radiological procedures and radiotherapy in the United...
The first scoping review of communication barriers for d/Deaf cancer patients finds only nine studies worldwide and documents systemic failures...
Neutrophils, the abundant white blood cells that form the first line of defense against bacteria, carry a hidden weapon that...
A matched study of more than 30,000 appendicitis patients found that those who underwent an appendectomy had a 58 percent...
A prospective study shows that ultrafast dynamic contrast-enhanced MRI kinetic parameters, particularly maximum slope and time-to-enhancement, can independently predict axillary...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine